Sign up
Pharma Capital

Sareum Holdings represents UK at cancer cluster conference

Sareum is one of three companies from the UK "Golden Triangle" biotechnology cluster.
picture of cells
Sareum will represent cluster of London, Cambridge and Oxford

Sareum Holdings Plc (LON:SAR) is to highlight its research pipeline at the 6th annual International Cancer Cluster Showcase at the San Diego Convention Center.

Tim Mitchell, chief executive, will be showcasing Sareum as one of three companies from the UK "Golden Triangle" biotechnology cluster (London, Oxford and Cambridge).

The event is organised as a satellite to the BIO International Convention, the world's largest gathering for the global biotech industry.

Over 200 representatives from the international oncology community are expected to participate in the network meeting.

Tim Mitchell said: "We are delighted that Sareum has been selected to represent British cancer research at this prestigious event."

Watch: Cancer drug payment nudges Sareum Holdings into maiden profit

 

 

 

PhilW.jpg
Why Invest In Sareum Holdings Plc? Read More Here

Register here to be notified of future SAR Company articles
View full SAR profile

Sareum Holdings Plc Timeline

View All

Related Articles

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.